Government’s Draft Guidelines on Drugs Are Murky At Best
The federal government’s drug industry fraud bloodhound—no, not James Sheehan, the U.S. attorney in Philadelphia—has drafted some guidelines on how pharmacy benefit managers (PBMs) might stay on the right side of the law. The Office of the Inspector General (OIG) at the Department of Health and Human Services is the one that does the initial [...]
